Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Brooks Life Science Systems Announces New Applications for Celigo® Imaging Cytometer

Published: Monday, January 14, 2013
Last Updated: Monday, January 14, 2013
Bookmark and Share
Company develops new and improved applications for use in cell line generation and oncology research.

Brooks Life Science Systems has announced that its ongoing investment and development of the Celigo® Imaging Cytometer is bringing new capabilities to academic research, biopharmaceutical drug development and high-throughput and high-content screening.

Celigo is a multi-application cell imaging cytometer able to perform high-content and high-throughput fluorescence and brightfield cellular imaging and analysis with minimal sample manipulation.

Following the acquisition of the Celigo Imaging Cytometer product earlier this year, Brooks Life Science Systems has developed a number of new and improved applications for use in cell line generation and oncology research.

New applications include:
• Tumor growth analysis in drug screening: brightfield and fluorescence acquisition of tumorspheres with fluorescence & morphologic measurements
• Single colony verification: enumeration of colonies within a well for identification of single clones
• Cell migration measurement: assessment of wound healing via typical scratch assays
• Faster automated measurement of cell counting & confluency
• Improved reproducibility and reliability of embryoid body segmentation

Dr Suzanne Eccles, Reader in Tumor Biology at the Institute of Cancer Research, Sutton commented, “Celigo has been essential to our work validating 3D models of tumor growth, invasion and angiogenesis. We now have robust, high-throughput growth assays, with results for 96-well plates in minutes compared with standard automated microscopy-based image analysis, and we have been able to develop novel quantitative, measurements of tumor invasion.

“By using the Celigo in our drug discovery research we have more clinically relevant models for drug evaluation which are contributing to a reduction in the amount of in vivo testing being performed.”

Clint Haris, Senior Vice President, General Manager, Brooks Life Science Systems added, “Cell analysis is a fast moving field that requires versatile instrumentation capable of meeting challenging demands. The development of these new applications is ensuring that Celigo continues to meet the needs of our customers and highlights our commitment to supporting the field of cell analysis.”

Brooks Celigo is designed for the rapid image capture and processing of cells with minimum plate movements and sample disturbance.

Proven with both adherent and non-adherent cell types, its high resolution image acquisition coupled with uniform, high contrast and even illumination allows identification of “every cell in every well”.

Compatibility with SBS multi-well plates along with T25 and T75 culture flasks, a simplified workflow for all assays and enhanced software capabilities, enables the Celigo to be used in a broad range of applications.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Revolutionary Technologies Developed to Improve Outcomes for Lung Cancer Patients
Breath test to detect lung cancer brings oxygen directly to the wound.
NIH Supports New Studies to Find Alzheimer’s Biomarkers in Down Syndrome
Initiative will track dementia onset, progress in Down syndrome volunteers.
Dementia Linked to Deficient DNA Repair
Mutant forms of breast cancer factor 1 (BRCA1) are associated with breast and ovarian cancers but according to new findings, in the brain the normal BRCA1 gene product may also be linked to Alzheimer’s disease.
Using Drug-Susceptible Parasites to Fight Drug Resistance
Researchers at the University of Georgia have developed a model for evaluating a potential new strategy in the fight against drug-resistant diseases.
Boosting Breast Cancer Treatment
To more efficiently treat breast cancer, scientists have been researching molecules that selectively bind to cancer cells and deliver a substance that can kill the tumor cells, for several years.
New Gene Map Reveals Cancer’s Achilles’ Heel
Team of researchers switches off almost 18,000 genes
New Discovery Sheds Light on Disease Risk
Gaps between genes interact to influence the risk of acquiring disease.
How Cells ‘Climb’ to Build Fruit Fly Tracheas
Mipp1 protein helps cells sprout “fingers” for gripping.
Research Finding Could Lead to Targeted Therapies for IBD
Findings published online in Cell Reports.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos